D. E. Shaw & Co., Inc. Abb Vie Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 626,907 shares of ABBV stock, worth $105 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

626,907

Holding current value

$105 Million

% of portfolio

0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $47.8 Million - $58.1 Million	-291,724 Reduced 31.76%	626,907 $124 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $27.7 Million - $32.3 Million	178,932 Added 24.19%	918,631 $158 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $52.1 Million - $59.4 Million	-326,055 Reduced 30.59%	739,699 $135 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $7.44 Million - $8.38 Million	-54,054 Reduced 4.83%	1,065,754 $165 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $72.7 Million - $84.1 Million	-543,840 Reduced 32.69%	1,119,808 $167 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $203 Million - $253 Million	1,532,290 Added 1166.5%	1,663,648 $224 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $739,246 - $851,352	5,112 Added 4.05%	131,358 $20.9 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.61 Million - $1.93 Million	11,663 Added 10.18%	126,246 $20.4 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.71 Million - $1.97 Million	12,772 Added 12.54%	114,583 $15.4 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $24.1 Million - $30.6 Million	-174,802 Reduced 63.19%	101,811 $15.6 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $327,442 - $406,263	2,481 Added 0.91%	276,613 $44.8 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $3.65 Million - $4.62 Million	33,958 Added 14.14%	274,132 $37.1 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $17.8 Million - $20.3 Million	167,678 Added 231.29%	240,174 $25.9 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $5.5 Million - $6.12 Million	52,250 Added 258.08%	72,496 $8.17 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1.3 Million - $1.43 Million	12,672 Added 167.31%	20,246 $2.19 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $50.8 Million - $68.6 Million	-630,923 Reduced 98.81%	7,574 $812,000
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $71.6 Million - $84 Million	-833,134 Reduced 56.61%	638,497 $55.9 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $170 Million - $227 Million	-2,314,812 Reduced 61.13%	1,471,631 $144 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $20 Million - $30.3 Million	-309,916 Reduced 7.57%	3,786,443 $288 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $84.8 Million - $106 Million	-1,175,131 Reduced 22.29%	4,096,359 $363 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $70.5 Million - $84.8 Million	-1,119,613 Reduced 17.52%	5,271,490 $399 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $19.5 Million - $24.9 Million	296,368 Added 4.86%	6,391,103 $465 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $384 Million - $452 Million	4,979,335 Added 446.42%	6,094,735 $491 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $51.4 Million - $63.4 Million	-660,112 Reduced 37.18%	1,115,400 $103 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $30 Million - $33.3 Million	-336,902 Reduced 15.95%	1,775,512 $168 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $37.4 Million - $44.3 Million	416,639 Added 24.57%	2,112,414 $196 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $65.2 Million - $87.3 Million	708,775 Added 71.81%	1,695,775 $161 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $11.5 Million - $12.6 Million	-128,673 Reduced 11.53%	987,000 $95.5 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $77.9 Million - $99.5 Million	1,115,673	1,115,673 $99.1 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account